A carregar...
Emerging and investigational therapies for neuroblastoma
INTRODUCTION: Treatment for children with clinically aggressive, high-risk neuroblastoma remains challenging. Less than 50% of patients with high-risk neuroblastoma will survive long-term with current therapies, and survivors are at risk for serious treatment-related late toxicities. Here, we review...
Na minha lista:
| Publicado no: | Expert Opin Orphan Drugs |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649635/ https://ncbi.nlm.nih.gov/pubmed/29062613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2017.1304212 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|